Heparin recall spreads in Europe

March 27, 2008

France, Italy and Denmark are recalling heparin after an Italian firm purchased contaminated ingredients from China, EU drug regulators said.

The drug has already been recalled in Germany and the United States.

The Wall Street Journal reported China's Shenzhen Hepalink Pharmaceutical Co., which supplies ingredients to U.S.-based APP Pharmaceuticals also supplied Italian company Opocrin. The Italian company said Tuesday it bought some ingredients from Shenzhen that turned out to be contaminated, the newspaper said.

APP said the Italian heparin ingredients were obtained through a different pig slaughterhouse and that APP heparin produced in the United States has consistently tested contaminant-free.

Copyright 2008 by United Press International

Related Stories

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.